¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2020³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ : 2020-11-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2020³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ : 2020-11-06
±³À°ÀÏÀÚ : 2020-11-06
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£È­»ó°­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ
´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ
¿¬¶ôó : 02-795-3094  
À̸ÞÀÏ : ksphe@kams.or.kr      
±³À°Á¾·ù : º´¸®°ú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 36ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í ´ëÇѺ´¸®ÇÐȸ Á¤È¸¿ø : 70,000¿ø/´ëÇѺ´¸®ÇÐȸ ÁØȸ¿ø(±ºÀÇ°üÆ÷ÇÔ) : 50,000/ ºñȸ¿ø : 100,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 09:00~10:00 Keynote Lecture (3):How Twitter and Facebook Changed My Life: The Role of SocialMedia in Pathology and Medicine  Jerad Gardner(Geisinger Medical Center) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 10:00~10:25 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-What''s new in the 2019 WHO for bone tumors  ¹Ú¿ë±¸(U2Bio) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 10:25~10:50 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Emphasis on Jaffe''s diagnostic triangle and management ofchodrosarcoma  ¹Ú¿øÁ¾(ÀÇÁ¤ºÎ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 10:50~11:15 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Pseudosarcomatous lesion  ±è°æÈñ(¼¼Á¾Ãæ³²´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 11:15~11:40 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Round cell soft tissue tumors  ±è»ó°â(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 11:40~11:50 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Q & A  () 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 11:50~12:00 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Quiz  () 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 13:00~14:00 Keynote Lecture (4):Classification of Renal Tumors: Past, Present, and Future(½ÅÀåÁ¾¾çÀÇ ºÐ·ù: °ú°Å, ÇöÀç, ¹Ì·¡)  ÃÖÂù(È­¼øÀü³²´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:00~14:12 ±¸¿¬B-Clinicopathological analysis of 14 patients with pediatric-type low grade B-cell lymphomas including pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma  ÀÓ¼ÒÁ¤(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:12~14:24 ±¸¿¬B-Comparison of Ki-67 Labeling Index Patterns of Diffuse Large B-Cell Lymphomas and Burkitt Lymphomas Using Image Analysis  Á¤¿ä¼Á(ÀÇÁ¤ºÎ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:24~14:36 ±¸¿¬B-Histologic sub and its relationship with the targetable genomic features in solid-predominant lung adenocarcinoma  ¾Èº¸°æ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:36~14:48 ±¸¿¬B-Comprehensive comparison of 22C3 and SP263 PD-L1 expression using routine clinical and conditioned archives of Non-Small-Cell Lung Cancer  ±èÅÂÁ¤(ÀÇÁ¤ºÎ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:48~15:00 ±¸¿¬B-CDX2 loss and SATB2 loss are differentially associated with underlying clinicopathologic and molecular features in colorectal carcinomas according to microsatellite instability status  ÀÌÁö¾Ö(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 15:00~15:12 ±¸¿¬B-PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression  ±èºû³ª¸®(¿ï»ê´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 15:12~15:24 ±¸¿¬B-Microvascular invasion-based integrated prognostic classification to predict survival in patients with hepatocellular carcinoma (HCC)  È²À±Á¤(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 15:24~15:36 ±¸¿¬B-Molecular risk stratification in metastatic differentiated thyroid cancers  Á¤Âù±Ç(¼­¿ï¼º¸ðº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2020³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ : 2020-11-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2020³â ´ëÇÑÇǺÎÁø±ÕÇÐȸ ¼øȸ¿¬¼ö±³À° : 2020-11-06
´ÙÀ½±Û ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ë±¸․°æºÏÁöȸ Á¦1Â÷ ¿¬¼ö±³À° : 2020-11-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20732 ¼­¿ï Á¦55Â÷ Ç×¹®Áúȯ¿¬±¸È¸ Áý´ãȸ : 2024-06-02 0 22 2024-05-27
20731 °­¿ø ´ëÇÑ°ñÀýÇÐȸ Á¦6ȸ »óÁö °ñÀý ½ÉÆ÷Áö¾ö : 2024-06-02 0 21 2024-05-27
20730 °­¿ø 2024³â °³¿øÀǸ¦ À§ÇÑ ³»°úÇÐ ¿¬¼ö°­Á : 2024-06-02 0 16 2024-05-27
20729 Ãæ³² Á¦16Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â_3ÀÏÂ÷) : 2024-06-02 0 42 2024-05-27
20728 ¼­¿ï 2024³â ´ëÇÑÀÇÇз¹ÀÌÀúÇÐȸ Á¦13Â÷ ¿¬¼ö±³À° : 2024-06-02 0 34 2024-05-27
20727 ¼­¿ï Á¦9ȸ °¡Á¤ÀÇ, È£½ºÇǽº ¿ÏÈ­ÀÇ·á Àü¹®°¡µÇ±â : 2024-06-01 0 46 2024-05-27
20726 ¼­¿ï ÀÌ´ë¼­¿ïº´¿ø »êºÎÀΰú Áö¿ªÀÇ»ç °£´ãȸ(Àӽżº °íÇ÷¾Ð ÁúȯÀÇ Á¶±â ¿¹Ãø°ú ¿¹¹æ) : 2024-06-01 0 72 2024-05-27
20725 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥(ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö) : 2024-06-01 0 54 2024-05-27
20724 ¼­¿ï °Ç±¹´ëÇб³º´¿ø ´ëÇÑÀÇÁø±ÕÇÐȸ Á¦30Â÷ Çмú´ëȸ : 2024-06-01 0 44 2024-05-27
20723 ¼­¿ï Á¦54Â÷ ´ëÇѼҾƽŰæ¹ß´ÞÇൿ¿¬±¸È¸ ÇмúÁý´ãȸ : 2024-06-01 0 55 2024-05-27
20722 °æ³² Á¦25ȸ °æ³²ÀÇ»çÀÇ ³¯ ±â³ä Á¾ÇÕÇмú´ëȸ[¿Â.¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ] : 2024-06-01 0 85 2024-05-27
20721 ÀüºÏ 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ÀüºÏÁöȸ Á¦12ȸ ¿¬¼ö°­Á : 2024-06-01 0 81 2024-05-27
20720 ¼­¿ï 2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01 0 60 2024-05-26
20719 ºÎ»ê Á¦516Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³²Áöȸ Çмú´ëȸ : 2024-06-01 0 69 2024-05-26
20718 °æ±â Àü¹®½ÉÀå¼Ò»ý¼ú(ACLS Provider) ½Ã¹Ä·¹À̼Ç(2day) : 2024-06-01 0 47 2024-05-26
31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷